Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Aurigene Discovery Technologies Limited patents


Recent patent applications related to Aurigene Discovery Technologies Limited. Aurigene Discovery Technologies Limited is listed as an Agent/Assignee. Note: Aurigene Discovery Technologies Limited may have other listings under different names/spellings. We're not affiliated with Aurigene Discovery Technologies Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Aurigene Discovery Technologies Limited-related inventors


Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators

The present invention relates to 3-substituted-1,2,4-oxadiazole and thiadiazole compounds of formula (i) or formula (ii) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

3-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulators

The present invention relates to 3-substituted 1,3,4-oxadiazole and thiadiazole compounds of formula (i) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

1,3,4-oxadiazole and thiadiazole compounds as immunomodulators

The present invention relates to 1,3,4-oxadiazole and thiadiazole compounds of formula (i) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited

. . ... Aurigene Discovery Technologies Limited

4,5-dihydroisoxazole derivatives as nampt inhibitors

The present invention provides 4,5-dihydroisoxazole derivatives of formula (i), which may be therapeutically useful, more particularly as nampt inhibitors. Wherein, ring a, l1, l2, x1, x2, x3, z, r1, r2, r3, r4, r5, m, n, p and q have the meanings given in the specification and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorder, caused by an elevated level of nicotinamide phosphoribosyltransferase (nampt) in a mammal. ... Aurigene Discovery Technologies Limited

Substituted indazole compounds as irak4 inhibitors

The present invention provides substituted indazole compound of formula (i) and pharmaceutically acceptable salts thereof, and their use to inhibit irak4 and/or for the treatment of diseases or disorders induced by irak4.. . ... Aurigene Discovery Technologies Limited

Cyclic peptidomimetic compounds as immunomodulators

The present invention relates to cyclic peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

The present invention relates to 1,3,4-oxadiazole and 1,3,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signalling pathway. The invention also refers to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

1,2,4-oxadiazole derivatives as immunomodulators

The present invention relates to 1,2,4-oxadiazole and 1,2,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signaling pathway. The invention also refers to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

03/30/17 / #20170088822

Crystalline structure of fabi from burkholderia pseudomallei

The present invention relates to drug targets for burkholderia pseudomallei. The invention provides a crystalline polypeptide derived from burkholderia pseudomallei comprising the amino acid sequence set forth in seq id no: 1. ... Aurigene Discovery Technologies Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Aurigene Discovery Technologies Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aurigene Discovery Technologies Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###